0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical
Recalled by Otsuka ICU Medical LLC

Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Otsuka ICU Medical LLC has recalled 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on November 5, 2025 and was initiated on October 27, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, with approximately 509,360 100 mL bags affected. The company behind the recall is Otsuka ICU Medical LLC, based in Austin, TX. The FDA describes the product as: “0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37”
Why was 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical recalled?
According to the FDA, the stated reason for the recall is: “Lack of Assurance of Sterility: Potential for flexible container leaks.” In plain terms, this recall relates to a sterility or contamination concern.
Sterile medicines, such as injectables and eye drops, must be completely free of microorganisms and stray particles. This recall means that sterility could not be assured or that contamination was found or suspected. Using a non-sterile product of this kind can cause infections, which is why these recalls are treated seriously.
What should you do?
If you think you may have bought 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, compare it against the product description and identifying codes (Lot # 1029921, Exp Date: 28 February 2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Otsuka ICU Medical LLC or your local health authority.
About this recall
This recall was distributed in TX. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- November 5, 2025
- Recall started
- October 27, 2025
- Distributed in
- TX
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical recalled?+
According to the FDA: Lack of Assurance of Sterility: Potential for flexible container leaks.
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0143-2026. Information last synced from the FDA on July 6, 2026.